Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1b Study of Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cell Therapy in Recurrent Ovarian Cancer
The goal of this research study is to evaluate the safety and effectiveness of the use of cytokine-induced memory-like (CIML) natural killer (NK) cell therapy …
Platinum-resistant Ovarian CancerRecurrent Ovary CancerOvarian Cancer+4 more
Dana-Farber Cancer InstituteNCT06321484
Phase 1
A Phase 1b Study of BCL-XL Degrader DT2216 in Combination With Weekly Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer
The purpose of this research study is determining the highest dose of the study drug DT2216 in combination with paclitaxel that can be safely and tolerably adm…
Ovarian CancerOvarian CarcinomaRecurrent Ovary Cancer+1 more
Elizabeth Stover, MD, PhDNCT06964009